Recent Drug Suppression Cases
Recent Drug Suppression Cases Bystolic (nebivolol HCL)AbbVie’s blood pressure drug, Bystolic, accountsfor nearly $1 billion in yearly US sales. In December2011, manufacturers began applying to market genericversions of Bystolic. AbbVie’s subsidiary, Forest, sued those manufacturers for patent infringement. Such lawsuits cause an automatic stay of FDA approvals, meaning a generic version […]
Recent Drug Suppression Cases Read More »